1570082-23-3

Upstream product

• 83171-39-5 4-(methylthio)benzylamine 
• 85-44-9 phthalic anhydride 
• 247569-44-4 2-(4-methylthiobenzyl)isoindol-1,3-dione 
• 1570082-20-0 [[4-[(1,3-dioxoisoindolin-2-yl)methyl]phenyl]-methyl-λ⁴-sulfanylidene]cyanamide 

Downstream Products

• 1570084-40-0 N-[[4-[(1,3-dioxoisoindolin-2-yl)methyl]phenyl]-methyl-oxo-λ⁶-sulfanylidene]-2,2,2-trifluoro-acetamide 
• 1570084-38-6 (4-(S-methyl-N-(methylsulfonyl)sulfonimidoyl)phenyl)methanamine 
• 1570084-42-2 2-[[4-(methylsulfonimidoyl)phenyl]methyl]isoindoline-1,3-dione 
• 1570084-44-4 2-(4-(S-methyl-N-(methylsulfonyl)sulfonimidoyl)benzyl)isoindoline-1,3-dione 
• 1570084-70-6 2-(4-(N-cyanomethyl-S-(methyl)sulfonimidoyl)benzyl)isoindoline-1,3-dione 
• 1570077-26-7 1-isopropyl-6-methyl-4-oxo-5-(3-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-carboxylic acid 4-(N,S-dimethylsulfonimidoyl)benzylamide 
• 1570084-82-0 2-(4-(N,S-dimethylsulfonimidoyl)benzyl)isoindoline-1,3-dione 
• 1570084-84-2 4-(N,S-dimethylsulfonimidoyl)benzylamine 
• 1570075-95-4 5-(3-(difluoromethyl)phenyl)-1-isopropyl-6-methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid 4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide 
• 1570075-94-3 5-(3-(difluoromethyl)phenyl)-1-isopropyl-6-methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid 4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide 
• 1570077-28-9 5-bromo-1-isopropyl-6-methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid 4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide 
• 1570080-82-8 [[4-(aminomethyl)phenyl]-methyl-oxo-λ⁶-sulfanylidene]cyanamide 
• 1570077-35-8 5-bromo-1-ethyl-6-methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid 4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide 
• 1570077-45-0 5-bromo-1-cyclobutyl-6-methyl-4-oxo-1,4-dihydropyridine-3-carboxylic acid 4-(N-cyano-S-(methyl)sulfonimidoyl)benzylamide 

Relevant academic research and scientific papers

SUBSTITUTED PYRIDONES AND PYRAZINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY

Substituted 2-pyridones and pyrazinones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other auto-immune and allergic disorders, allograft rejection and oncological diseases.

SUBSTITUTED 4-PYRIDONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY

This invention relates to substituted 4-pyridones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other auto-immune and allergic disorders, allograft rejection, and oncological diseases.

SUBSTITUTED 4-PYRIDONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY

This invention relates to substituted 4-pyridones of formula (1) and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other auto-immune and allergic disorders, allograft rejection, and oncological diseases.